New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder

Archives of Women's Mental Health

Volumn 4, Issue 4, 2002, Pages 111-119

  Eriksson, E ^a   Endicott, J ^b   Andersch, B ^a   Angst, J ^c   Demyttenaere, K ^d   Facchinetti, F ^e   Lanczik, M ^f   Montgomery, S ^g   Muscettola, G ^h   O'Brien, P M S ⁱ   Studd, J ^j   Sundblad, C ^a   Young, A H ^k  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Columbia University ^*  (United States)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^j LISTER HOSPITAL   (United Kingdom)

^k ROYAL VICTORIA INFIRMARY   (United Kingdom)

more..

Author keywords

Premenstrual dysphoric disorder; Premenstrual syndrome

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; BROMOCRIPTINE; CITALOPRAM; CLOMIPRAMINE; DANAZOL; DESIPRAMINE; ESTRADIOL; ESTROGEN; FLUOXETINE; GONADORELIN DERIVATIVE; MAGNESIUM; MAPROTILINE; PAROXETINE; PRIMROSE OIL; PROGESTERONE; PYRIDOXINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEX HORMONE;

ALGORITHM; BEHAVIOR THERAPY; CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; HORMONE SUBSTITUTION; HUMAN; MENTAL DISEASE; NAUSEA; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 18444389462     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007370200009     Document Type: Review

References (79)

1. Bromocriptine and premenstrual symptoms: A survey of double blind trials
2. Premenstrual complaints I. Prevalence of premenstrual symptoms in a Swedish urban population
3. The epidemiology of perimenstrual psychological symptoms
4. Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations
5. The premenstrual syndrome: A reappraisal of the concept and the evidence
6. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving, and other symptoms
7. The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes
8. Women's health: Consumer views for planning local health promotion and health care priorities
9. Is evening primrose oil of value in the treatment of premenstrual syndrome?
10. Premenstrual symptoms. Prevalence and severity in an adolescent sample
11. Premenstrual symptoms in general practice patients. Prevalence and treatment
12. Long-term efficacy of fluoxetine in premenstrual dysphoric disorder
13. Biological, social, and behavioral factors associated with premenstrual syndrome
14. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
15. Is premenstrual dysphoric disorder a distinct clinical entity?
16. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria
17. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome
18. Oral magnesium successfully relieves premenstrual mood changes
19. The hormonal causes of premenstrual tension
20. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome
21. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
22. Fluoxetine effects on serotonin function and aggressive behavior
23. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome
24. The premenstrual syndrome - An equivalent of depression?
25. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo
26. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome
27. The incidence of premenstrual tension in a gynecologic clinic
28. Treatment of premenstrual dysphoria with alprazolam. A controlled study
29. Premenstrual dysphoria: A Community survey
30. Can one induce premenstrual symptomatology in women with prior hysterectomy and bilateral oophorectomy?
31. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: An animal model of premenstrual irritability?
32. Buserelin in premenstrual syndrome
33. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study
34. Epidemiology of premenstrual symptoms in a nonclinical sample
35. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study
36. Vitamin B6 in the treatment of the premenstrual syndrome - A review
37. Premenstrual syndromes
38. The treatment of severe premenstrual syndrome with goserelin with and without "add-back" estrogen therapy: A placebo-controlled study
39. Perimenstrual symptoms: Prevalence and risk factors
40. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: Placebo controlled study
41. The Zurich Study. XIX. Patterns of menstrual disturbance in the community: Results of the Zurich Cohort Study
42. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome
43. Pharmacologic strategies for managing premenstrual syndrome
44. Perimenstrual symptom prevalence rates: An Italian-American comparison
45. A comparison of hormone therapy, coping skills training, and relaxation for the relief of premenstrual syndrome
46. Clinical experience with the use of GnRH agonists in the treatment of premenstrual syndrome
47. The premenstrual syndrome. Effects of "medical ovariectomy"
48. Treatment of premenstrual syndrome by spironolactone
49. Non-antidepressant treatment of premenstrual syndrome
50. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder
51. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo
52. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors
53. Late luteal phase dysphoric disorder in young women
54. The role of fluoxetine in the treatment of premenstrual dysphoric disorder
55. Premenstrual syndrome: Beneficial effects of periodic, low-dose danazol
56. Treatment for the premenstrual syndrome with agnus castus fruit extract: Prospective, randomised, placebo controlled study
57. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial
58. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
59. Premenstrual syndrome in France: Epidemiology and therapeutic effectiveness of 1,000mg of micronized purified flavonoid fraction in 1,473 gynecological patients
60. Incidence of premenstrual syndrome and remedy usage: A national probability sample study
61. Fluoxetine in the treatment of premenstrual dysphoria
62. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria
63. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder
64. Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo controlled trial
65. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial
66. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms
67. The premenstrual syndrome: An epidemiological and statistical exercise
68. Treatment of severe premenstrual syndrome with estradiol patches and cyclical oral norethisterone
69. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
70. A survey of adolescent dysmenorrhea and premenstrual symptom frequency. A model program for prevention, detection, and treatment
71. Prevalence of perimenstrual symptoms
72. Efficacy of progesterone and progestogens in management of premenstrual syndrome: Systematic review
73. The association between premenstrual dysphoric disorder and other mood disorders
74. Medical management of premenstrual dysphoric disorder
75. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial
76. Serial discontinuation of selective serotonin reuptake inhibitors treatment for PMDD
77. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial